Chemoinformaics analysis of 6-Bromo-1-hexanethiol
Molecular Weight | 197.141 | nRot | 5 |
Heavy Atom Molecular Weight | 184.037 | nRig | 0 |
Exact Molecular Weight | 195.992 | nRing | 0 |
Solubility: LogS | -3.094 | nHRing | 0 |
Solubility: LogP | 3.278 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 24.6383 |
nHD | 1 | BPOL | 16.8817 |
QED | 0.391 |
Synth | 2.646 |
Natural Product Likeliness | 0.337 |
NR-PPAR-gamma | 0.008 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0 |
HIA | 0.005 |
CACO-2 | -4.395 |
MDCK | 0.000024 |
BBB | 0.063 |
PPB | 0.973058 |
VDSS | 3.186 |
FU | 0.0486453 |
CYP1A2-inh | 0.879 |
CYP1A2-sub | 0.75 |
CYP2c19-inh | 0.164 |
CYP2c19-sub | 0.479 |
CYP2c9-inh | 0.102 |
CYP2c9-sub | 0.781 |
CYP2d6-inh | 0.017 |
CYP2d6-sub | 0.651 |
CYP3a4-inh | 0.019 |
CYP3a4-sub | 0.132 |
CL | 5.626 |
T12 | 0.568 |
hERG | 0.01 |
Ames | 0.892 |
ROA | 0.143 |
SkinSen | 0.89 |
Carcinogencity | 0.728 |
EI | 0.995 |
Respiratory | 0.952 |
NR-Aromatase | 0.013 |
Antiviral | No |
Prediction | 0.952109 |